Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 44, Issue 2, 2006, Pages 326-332

  Vainas, Tryfon ^a,b   Stassen, Frank R M ^a,b   Bruggeman, Cathrien A ^a,b   Welten, Rob J Th J ^c   van den Akker, Luc H J M ^c   Kitslaar, Peter J E H M ^a,b   Peña, Amado S ^d   Morré, Servaas A ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; AGED; AORTA; ARTERY; ARTERY DISEASE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN ARTERY; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTIGENS, CD14; ATHEROSCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LOGISTIC MODELS; MALE; NETHERLANDS; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 33746508508     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.04.035     Document Type: Article

References (35)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Hansson G.K., Libby P., Schonbeck U., and Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 (2002) 281-291
3. Leinonen M., and Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2 (2002) 11-17
4. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
5. Poltorak A., Ricciardi-Castagnoli P., Citterio S., and Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A 97 (2000) 2163-2167
6. Werling D., and Jungi T.W. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 91 (2003) 1-12
7. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
8. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
9. Cooke G.S., Segal S., Hill A.V.S., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 1978-1980
10. Ameziane N., Beillat T., Verpillat P., et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23 (2003) e61-e64
11. Boekholdt S.M., Agema W.R., Peters R.J., et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107 (2003) 2416-2421
12. Risley P., Jerrard-Dunne P., Sitzer M., Buehler A., von Kegler S., and Markus H.S. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers. the Carotid Atherosclerosis Progression Study (CAPS). Stroke 34 (2003) 600-604
13. Lichy C., Meiser H., Grond-Ginsbach C., Buggle F., Dorfer C., and Grau A. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol 249 (2002) 821-823
14. Hubacek J.A., Rothe G., Pit'ha J., et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
15. Shimada K., Watanabe Y., Mokuno H., Iwama Y., Daida H., and Yamaguchi H. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86 (2000) 682-684 A8
16. Ito D., Murata M., Tanahashi N., et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31 (2000) 2661-2664
17. Longobardo M.T., Cefalu A.B., Pezzino F., et al. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 3 (2003) 161-165
18. Zee R.Y., Bates D., and Ridker P.M. A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke. Stroke 33 (2002) 892-895
19. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
20. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35 (1997) 2-3
21. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
22. Morre S.A., Murillo L.S., Spaargaren J., Fennema H.S., and Pena A.S. Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis 186 (2002) 1377-1379 author reply 1379
23. Morre S.A., Murillo L.S., Bruggeman C.A., and Pena A.S. The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility. J Infect Dis 187 (2003) 341-342 author reply 342-3
24. Read R.C., Pullin J., Gregory S., et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 184 (2001) 640-642
25. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
26. Sonecha T.N., and Delis K.T. Prevalence and distribution of coronary disease in claudicants using 12-lead precordial stress electrocardiography. Eur J Vasc Endovasc Surg 25 (2003) 519-526
27. Dormandy J., Heeck L., and Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process. implications for concomitant coronary and carotid disease. Semin Vasc Surg 12 (1999) 118-122
28. Rumberger J.A., Sheedy II P.F., Breen J.F., Fitzpatrick L.A., and Schwartz R.S. Electron beam computed tomography and coronary artery disease. scanning for coronary artery calcification. Mayo Clin Proc 71 (1996) 369-377
29. Chan S.K., Jaffer F.A., Botnar R.M., et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J Cardiovasc Magn Reson 3 (2001) 331-338
30. Stary H.C. Natural history and histological classification of atherosclerotic lesions. an update. Arterioscler Thromb Vasc Biol 20 (2000) 1177-1178
31. LeVan T.D., Bloom J.W., Bailey T.J., et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167 (2001) 5838-5844
32. Eng H.L., Chen C.H., Kuo C.C., Wu J.S., Wang C.H., and Lin T.M. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. J Infect Dis 188 (2003) 90-97
33. Eng H.L., Wang C.H., Chen C.H., Chou M.H., Cheng C.T., and Lin T.M. A CD14 promotor polymorphism is associated with CD14 expression and Chlamydia-stimulated TNFalpha production. Genes Immun 5 (2004) 426-430
34. Vercelli D. Genetic polymorphism in allergy and asthma. Curr Opin Immunol 15 (2003) 609-613
35. Erridge C., Stewart J., and Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 197 (2003) 1787-1791